-
Portugal's Silva bides his time after being benched at World Cup
-
LeBron James to leave Lakers to play 24th NBA season
-
US stars relish soccer's primetime moment against Bosnia
-
Zverev wins in four sets to reach Wimbledon round two
-
Lampard extends Coventry stay after promotion to Premier League
-
Grimaldo realises goal of Atletico Madrid move from Leverkusen
-
Djokovic, Sinner aim to step up Wimbledon title chase
-
US Supreme Court lifts campaign spending restrictions ahead of midterms
-
Brook ready for "great honour" of succeeding Stokes as Test skipper
-
LeBron James to leave Lakers to play 24th NBA career
-
Taps run dry in Hungarian village as heatwave bites
-
Tens of millions swelter as heat wave blasts US
-
Venezuela quake survivors seek food, shelter amid risk of disease outbreaks
-
US Supreme Court rejects Trump bid to limit birthright citizenship
-
LeBron James to leave Lakers, continue NBA career - media reports
-
Gardner stars as Australia thrash the West Indies in Women's T20 World Cup semi-final
-
'Where is she?' The desperate search for Venezuela's missing
-
Former Barca teen star Fati seals permanent Monaco switch
-
No business as usual after shock World Cup exit, say German FA
-
German rail regulator backs Italian firm in competition spat
-
Pope appeals to Catholic traditionalists to avoid schism
-
Ancelotti shows Brazil his worth at World Cup but concerns remain
-
US Supreme Court upholds transgender sports bans
-
Stocks rise, yen at 40-year low against dollar
-
US Supreme Court rejects Trump bid to restrict birthright citizenship
-
Australia hold West Indies to 125-7 in World Cup semi-final
-
Serena set for remarkable Wimbledon return, Swiatek survives scare
-
Defending champ Swiatek survives scare to reach Wimbledon second round
-
Africa EV firm Spiro accused of torturing Uganda employees
-
US Supreme Court upholds state bans on transgender athletes in school
-
PSG's Portugal forward Ramos signs five-year AC Milan deal
-
Tourists soldier on in Rome despite heatwave
-
Inflation slows in top eurozone economies as ECB ponders next move
-
Record number of 'new millionaires' in 2025, says UBS
-
Starmer boosts budget to modernise UK military before exit
-
UN calls for food, shelter to help Venezuela quake survivors
-
Stocks mostly higher, yen stays near 40-year low against dollar
-
Merz faces mockery over praise of Germany's World Cup team
-
Data centres emitting more CO2 than thought: study
-
Ride-share group BlaBlaCar taps AI for 20-country expansion
-
Over 1 million migrants apply for Spain's mass regularisation
-
Escaping heat, forgetting war: Kyiv locals hit the beach
-
Germany questions footballing identity after fresh World Cup failure
-
Thousands march to demand illegal migrants leave South Africa
-
MEXC Lists Ondo's Tokenized Strategy Preferred Stock on Spot Market
-
Serena set for remarkable Wimbledon return
-
Stocks climb, yen stays near 40-year low against dollar
-
Outgoing UK PM Starmer announces 'record' defence spending
-
Swim star Marchand limps out of French nationals as Europeans loom
-
Paralluelo joins Barca women's departures
Landmark agreement reached at WHO over tackling future pandemics
Years of negotiations culminated in the wee small hours of Wednesday with countries agreeing the text of a landmark accord on how to tackle future pandemics, aimed at avoiding a repeat of the mistakes made during the Covid-19 crisis.
After more than three years of talks and a final marathon session, weary delegates at the World Health Organization's headquarters could finally pop the champagne corks at around 2:00 am (0000 GMT) Wednesday.
"The nations of the world made history in Geneva today," WHO chief Tedros Adhanom Ghebreyesus said in a statement.
"In reaching consensus on the Pandemic Agreement, not only did they put in place a generational accord to make the world safer, they have also demonstrated that multilateralism is alive and well, and that in our divided world, nations can still work together to find common ground, and a shared response to shared threats."
Five years after Covid-19 killed millions of people and devastated economies, a growing sense of urgency hung over the talks at a time when new health threats ranging from H5N1 bird flu to measles, mpox and Ebola were lurking.
The final stretch of negotiations also took place with cuts to US foreign aid spending and threatened tariffs on pharmaceuticals casting a new shadow over the talks.
- 'It's adopted' -
Right until the last minute, disagreement had lingered over a few thorny issues.
Negotiators had stumbled over the agreement's Article 11, which deals with transferring technology for pandemic health products, sources told AFP.
During the Covid-19 pandemic, poorer countries accused rich nations of hoarding vaccines and tests.
Countries that have large pharmaceutical industries have strenuously opposed the idea of mandatory tech transfers, insisting they be voluntary.
It appeared the tech transfer obstacle could be overcome by adding that any transfer needed to be "mutually agreed".
In the end, the 32-page agreement was entirely highlighted in green, indicating it had been fully approved by WHO member states.
"It's adopted," Anne-Claire Amprou, co-chair of the negotiations, announced to thundering applause.
The finalised text will now be presented for sign-off at the WHO's annual assembly next month.
As intense talks in corridors and closed rooms continued at the WHO headquarters, Tedros joined the negotiations late Tuesday and told reporters he thought the current draft was "good", "balanced" and that a deal would bring "more equity".
While taking measures to coordinate pandemic prevention, preparedness and response could be costly, Tedros insisted that "the cost of inaction is much bigger".
"Virus is the worst enemy. (It) could be worse than a war," he said.
The United States, which has thrown the global health system into crisis by slashing foreign aid spending, was not present. US President Donald Trump ordered a withdrawal from the United Nations' health agency and from the pandemic agreement talks after taking office in January.
However, the US absence, and Trump's threat to slap steep tariffs on pharmaceutical products, still hung over the talks, making manufacturers and governments more jittery.
But in the end, countries reached consensus.
"The world is watching us, and you can be very proud of what you have just achieved," Amprou said.
I.Meyer--BTB